세계의 주사기 시장 예측(2025-2030년)

The global syringe market is expected to grow from USD 10.491 billion in 2025 to USD 15.148 billion in 2030, at a CAGR of 7.62%.

The global syringe market is poised for significant growth, driven by the increasing prevalence of chronic diseases and a rapidly aging population. The rising demand for syringes is closely tied to the need for regular medical interventions, such as insulin administration for diabetes and drug delivery for other chronic conditions. Additionally, growing global immunization programs and heightened awareness of their importance further propel market expansion. While challenges such as high production costs and supply chain complexities may hinder growth, the market is supported by robust demand, particularly in regions with high disease prevalence and advanced healthcare systems like the United States.

Key Growth Drivers

Rising Prevalence of Chronic Diseases

The global increase in chronic diseases, particularly diabetes, cardiovascular conditions, and cancer, is a major driver of the syringe market. The need for frequent injections, such as insulin for diabetes management, significantly boosts syringe demand. The growing incidence of non-communicable diseases (NCDs), including cardiovascular illnesses, cancers, and chronic respiratory conditions, further fuels the need for syringes in treatment and management protocols. This trend is expected to continue, driven by lifestyle factors and increasing healthcare access worldwide.

Aging Population

The global rise in the geriatric population significantly contributes to market growth, as elderly individuals are more prone to chronic conditions requiring injectable treatments. With aging populations increasing worldwide, the demand for syringes for drug administration and disease management is expected to rise, particularly for conditions like diabetes and rheumatoid arthritis, which often necessitate regular injections.

Growing Immunization Programs

Increased global awareness of immunization's role in preventing diseases has led to expanded vaccination programs, driving syringe demand. These programs, supported by governments and health organizations, emphasize the need for safe and efficient syringe solutions, further bolstering market growth as populations seek protection against infectious and chronic diseases.

Market Segmentation

By Geography

The syringe market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. The United States is a key market, driven by the high prevalence of chronic diseases like diabetes and cancer, which require frequent syringe use for treatments such as insulin injections and chemotherapy. The country's advanced healthcare infrastructure and focus on innovation further support market growth. Asia-Pacific is expected to witness rapid expansion due to increasing healthcare investments and a growing patient pool in countries like India and China.

Competitive Landscape

Key players, such as Terumo Pharmaceutical Solutions and Nephron Pharmaceuticals Corporation, are driving innovation in the syringe market. These companies focus on developing advanced syringe solutions, such as polymer and cyclic olefin copolymer (COC) syringes, tailored for high-viscosity biotech drugs and improved durability, meeting the evolving needs of the healthcare industry.

The global syringe market is set for robust growth, propelled by the rising prevalence of chronic diseases, an aging population, and expanding immunization programs. The United States leads due to its high disease burden and advanced healthcare systems, while Asia-Pacific shows strong growth potential. Despite challenges like production costs, innovations in syringe design and materials by key players ensure the market's positive trajectory, addressing critical needs in chronic disease management and vaccination efforts.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Type

• Insulin Syringe
• Disposable Syringes
• Conventional Syringe
• Eccentric Tip Syringe
• Catheter Tip Syringe
• Luer Lock Syringe
• Safety Syringes
• Prefilled Syringes
• Others

By Material

• Glass
• Plastic
• Stainless Steel

By Syringe Size

• Smaller Volume Syringe
• Larger Volume Syringe

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL SYRINGE MARKET BY TYPE

• 5.1. Introduction
• 5.2. Insulin Syringe
• 5.3. Disposable Syringes
  • 5.3.1. Conventional Syringe
    • 5.3.1.1. Eccentric Tip Syringe
    • 5.3.1.2. Catheter Tip Syringe
    • 5.3.1.3. Luer Lock Syringe
  • 5.3.2. Safety Syringes
  • 5.3.3. Prefilled Syringes
• 5.4. Others

6. GLOBAL SYRINGE MARKET BY MATERIAL

• 6.1. Introduction
• 6.2. Glass
• 6.3. Plastic
• 6.4. Stainless Steel

7. GLOBAL SYRINGE MARKET BY SYRINGE SIZE

• 7.1. Introduction
• 7.2. Smaller Volume Syringe
• 7.3. Larger Volume Syringe

8. GLOBAL SYRINGE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Others
• 8.5. Middle East & Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Taiwan
  • 8.6.6. Thailand
  • 8.6.7. Indonesia
  • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Becton, Dickinson and Company
• 10.2. B. Braun Melsungen
• 10.3. Terumo
• 10.4. Teleflex
• 10.5. Nipro
• 10.6. ICU Medical
• 10.7. Cardinal Health
• 10.8. HMD Healthcare
• 10.9. Hamilton Company
• 10.10. Advancecare Pharma USA
• 10.11. Baxter International

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations